BCYC
Price
$6.82
Change
-$0.17 (-2.43%)
Updated
Dec 26 closing price
Capitalization
473.09M
65 days until earnings call
Intraday BUY SELL Signals
TSHA
Price
$5.83
Change
-$0.08 (-1.35%)
Updated
Dec 26 closing price
Capitalization
1.6B
66 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCYC vs TSHA

Header iconBCYC vs TSHA Comparison
Open Charts BCYC vs TSHABanner chart's image
Bicycle Therapeutics
Price$6.82
Change-$0.17 (-2.43%)
Volume$158.06K
Capitalization473.09M
Taysha Gene Therapies
Price$5.83
Change-$0.08 (-1.35%)
Volume$1.14M
Capitalization1.6B
BCYC vs TSHA Comparison Chart in %
BCYC
Daily Signal:
Gain/Loss:
TSHA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BCYC vs. TSHA commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Buy and TSHA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 28, 2025
Stock price -- (BCYC: $6.82 vs. TSHA: $5.83)
Brand notoriety: BCYC and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 51% vs. TSHA: 32%
Market capitalization -- BCYC: $473.09M vs. TSHA: $1.6B
BCYC [@Biotechnology] is valued at $473.09M. TSHA’s [@Biotechnology] market capitalization is $1.6B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, TSHA is a better buy in the long-term than BCYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 2 TA indicator(s) are bullish while TSHA’s TA Score has 6 bullish TA indicator(s).

  • BCYC’s TA Score: 2 bullish, 6 bearish.
  • TSHA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, TSHA is a better buy in the short-term than BCYC.

Price Growth

BCYC (@Biotechnology) experienced а -0.73% price change this week, while TSHA (@Biotechnology) price change was +6.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Reported Earning Dates

BCYC is expected to report earnings on Mar 03, 2026.

TSHA is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($1.6B) has a higher market cap than BCYC($473M). TSHA YTD gains are higher at: 236.994 vs. BCYC (-51.286). TSHA has higher annual earnings (EBITDA): -98.71M vs. BCYC (-245.86M). BCYC has more cash in the bank: 648M vs. TSHA (297M). BCYC has less debt than TSHA: BCYC (5.74M) vs TSHA (69M). BCYC has higher revenues than TSHA: BCYC (28.3M) vs TSHA (6.31M).
BCYCTSHABCYC / TSHA
Capitalization473M1.6B30%
EBITDA-245.86M-98.71M249%
Gain YTD-51.286236.994-22%
P/E RatioN/A2.70-
Revenue28.3M6.31M448%
Total Cash648M297M218%
Total Debt5.74M69M8%
FUNDAMENTALS RATINGS
BCYC: Fundamental Ratings
BCYC
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
80
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCTSHA
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BCYC
Daily Signal:
Gain/Loss:
TSHA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
THOFX48.010.25
+0.52%
Thornburg Global Opportunities R5
JIGIX35.170.12
+0.34%
JHancock International Growth R4
FGETX24.600.05
+0.20%
Fidelity Advisor Glbl Capital Apprec M
GWILX8.830.01
+0.11%
Glenmede SMID Core Equity Advisor
PRNIX29.24-0.02
-0.07%
Virtus NFJ Mid-Cap Value Inst

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with NRIX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-2.43%
NRIX - BCYC
51%
Loosely correlated
-0.31%
NGNE - BCYC
50%
Loosely correlated
-0.30%
XNCR - BCYC
49%
Loosely correlated
-1.49%
SYRE - BCYC
49%
Loosely correlated
-0.33%
RGNX - BCYC
48%
Loosely correlated
-2.07%
More

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with PCVX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
-1.35%
PCVX - TSHA
51%
Loosely correlated
-1.43%
NGNE - TSHA
50%
Loosely correlated
-0.30%
RGNX - TSHA
47%
Loosely correlated
-2.07%
BEAM - TSHA
44%
Loosely correlated
-0.57%
BCYC - TSHA
43%
Loosely correlated
-2.43%
More